This Article Full Text Full Text (PDF) All Versions of this Article: 35/6/1421    most recent 01.STR.0000126890.63512.41v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Barber, M. Articles by Stott, D. J. Search for Related Content PubMed PubMed Citation Articles by Barber, M. Articles by Stott, D. J. Pubmed/NCBI databases Medline Plus Health Information Stroke Related Collections Fibrinogen/fibrin Thrombin Acute Cerebral Infarction Anticoagulants Coagulation and fibronolysis

(Stroke. 2004;35:1421.)
© 2004 American Heart Association, Inc.

Original Contributions

Hemostatic Function and Progressing Ischemic Stroke

D-dimer Predicts Early Clinical Progression

Mark Barber, MRCP; Peter Langhorne, PhD, FRCP; Ann Rumley, PhD; Gordon D.O. Lowe, MD, FRCP David J. Stott, MD, FRCP

From University Section of Clinical Gerontology and Vascular Medicine, Royal Infirmary, Glasgow, UK.

Correspondence to Dr Mark Barber, Academic Section of Geriatric Medicine, 3rd Floor, Centre Block, Royal Infirmary, 84 Castle Street, Glasgow, G4 OSF, UK. E-mail M.Barber{at}clinmed.gla.ac.uk

Background and Purpose— Early clinical progression of ischemic stroke is common and is associated with increased risk of death and dependency. We hypothesized that activation of the coagulation system is an important contributor in some cases of deterioration. We aimed to characterize alterations in circulating hemostatic markers in patients with progressing stroke.

Methods— Consecutive acute ischemic stroke admissions were recruited. Progressing stroke was defined by deterioration in components of the Scandinavian Stroke Scale. Hemostatic markers (coagulation factors VIIc, VIIIc, and IXc, prothrombin fragments 1+2 [F1+2], thrombin–antithrombin complexes [TAT], D-dimer, fibrinogen, von Willebrand factor [vWF] and tissue plasminogen activator) were measured within 24 hours of symptom recognition.

Results— Fifty-four (25%) of the 219 patients met criteria for progressing stroke. F1+2 (median 1.28 versus 1.06 nmol/L, P=0.01), TAT (5.28 versus 4.07 µg/L, P<0.01), D-dimer (443 versus 194 ng/mL, P<0.001) and vWF (216 versus 198 IU/dL, P<0.05) levels were higher in these patients than in stable/improving patients. In logistic regression analysis, with all important clinical and laboratory variables included, only natural log D-dimer (odds ratio [OR]: 1.87; 95% confidence interval [CI]: 1.38 to 2.54; P=0.0001) and mean arterial blood pressure (OR: 1.26 per 10 mm Hg change; 95% CI: 1.05 to 1.51; P=0.01) remained independent predictors of progressing stroke.

Conclusions— There is evidence of excess thrombin generation and fibrin turnover in patients with progressing ischemic stroke. Measurement of D-dimer levels can identify patients at high risk for stroke progression. Further research is required to determine whether such patients benefit from acute interventions aimed at modifying hemostatic function.

Key Words: cerebral infarction • hemostasis • fibrin • blood pressure

This article has been cited by other articles:

				D.-W. Kang, S.-H. Yoo, S. Chun, K.-Y. Kwon, S. U. Kwon, J.-Y. Koh, and J. S. Kim Inflammatory and Hemostatic Biomarkers Associated With Early Recurrent Ischemic Lesions in Acute Ischemic Stroke Stroke, May 1, 2009; 40(5): 1653 - 1658. [Abstract] [Full Text] [PDF]

				W. Whiteley, W. L. Chong, A. Sengupta, and P. Sandercock Blood Markers for the Prognosis of Ischemic Stroke: A Systematic Review Stroke, May 1, 2009; 40(5): e380 - e389. [Abstract] [Full Text] [PDF]

				D. T. Laskowitz, S. E. Kasner, J. Saver, K. S. Remmel, E. C. Jauch, and BRAIN Study Group Clinical Usefulness of a Biomarker-Based Diagnostic Test for Acute Stroke: The Biomarker Rapid Assessment in Ischemic Injury (BRAIN) Study Stroke, January 1, 2009; 40(1): 77 - 85. [Abstract] [Full Text] [PDF]

				J. Kwan and P. Hand Early neurological deterioration in acute stroke: clinical characteristics and impact on outcome QJM, September 1, 2006; 99(9): 625 - 633. [Abstract] [Full Text] [PDF]

				P. Delgado, J. Alvarez-Sabin, S. Abilleira, E. Santamarina, F. Purroy, J. F. Arenillas, C. A. Molina, I. Fernandez-Cadenas, A. Rosell, and J. Montaner Plasma d-dimer predicts poor outcome after acute intracerebral hemorrhage. Neurology, July 11, 2006; 67(1): 94 - 98. [Abstract] [Full Text] [PDF]

				S. Juvela and J. Siironen D-Dimer as an Independent Predictor for Poor Outcome After Aneurysmal Subarachnoid Hemorrhage Stroke, June 1, 2006; 37(6): 1451 - 1456. [Abstract] [Full Text] [PDF]

				M. Barber, P. Langhorne, A. Rumley, G. D.O. Lowe, and D. J. Stott D-Dimer Predicts Early Clinical Progression in Ischemic Stroke: Confirmation Using Routine Clinical Assays Stroke, April 1, 2006; 37(4): 1113 - 1115. [Abstract] [Full Text] [PDF]

				M. J. O'Donnell, E. Berge, and P. M. Sandset Are There Patients With Acute Ischemic Stroke and Atrial Fibrillation That Benefit From Low Molecular Weight Heparin? Stroke, February 1, 2006; 37(2): 452 - 455. [Abstract] [Full Text] [PDF]